Glenmark Pharma rallies on Germany marketing nod

Glenmark Pharma rallies on Germany marketing nod

Monday, September 10, 2018

Share prices of Glenmark Pharmaceuticals rose over 3 percent early Monday as its subsidiary Glenmark Arzneimittel secured marketing authorization for a dry powder inhaler in Germany.
The drug, Fluticasone/Salmeterol dry powder inhaler (DPI), is a generic version of GlaxoSmithKline’s Seretide Accuhaler.

For more information on Indian Share Market Tips For Tomorrow

and quick free trial click here > 911 133 9000

Visit http://www.epicresearch.co

Connect with our social media sites
Next
« Prev Post
Previous
Next Post »